These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1453 related items for PubMed ID: 9406705

  • 21. The optimal fraction size in high-dose-rate brachytherapy: dependency on tissue repair kinetics and low-dose rate.
    Sminia P, Schneider CJ, Fowler JF.
    Int J Radiat Oncol Biol Phys; 2002 Mar 01; 52(3):844-9. PubMed ID: 11849810
    [Abstract] [Full Text] [Related]

  • 22. Radioimmunotherapy of a human lung cancer xenograft with monoclonal antibody RS7: evaluation of (177)Lu and comparison of its efficacy with that of (90)Y and residualizing (131)I.
    Stein R, Govindan SV, Chen S, Reed L, Richel H, Griffiths GL, Hansen HJ, Goldenberg DM.
    J Nucl Med; 2001 Jun 01; 42(6):967-74. PubMed ID: 11390564
    [Abstract] [Full Text] [Related]

  • 23. Comparison of 131I- and 90Y-labeled monoclonal antibody 17-1A for treatment of human colon cancer xenografts.
    Buchsbaum DJ, Lawrence TS, Roberson PL, Heidorn DB, Ten Haken RK, Steplewski Z.
    Int J Radiat Oncol Biol Phys; 1993 Mar 15; 25(4):629-38. PubMed ID: 8454481
    [Abstract] [Full Text] [Related]

  • 24. Radioimmunotherapy of human head and neck squamous cell carcinoma xenografts with 131I-labelled monoclonal antibody E48 IgG.
    Gerretsen M, Schrijvers AH, van Walsum M, Braakhuis BJ, Quak JJ, Meijer CJ, Snow GB, van Dongen GA.
    Br J Cancer; 1992 Sep 15; 66(3):496-502. PubMed ID: 1520586
    [Abstract] [Full Text] [Related]

  • 25. Radioimmunotherapy for model B cell malignancies using 90Y-labeled anti-CD19 and anti-CD20 monoclonal antibodies.
    Ma D, McDevitt MR, Barendswaard E, Lai L, Curcio MJ, Pellegrini V, Brechbiel MW, Scheinberg DA.
    Leukemia; 2002 Jan 15; 16(1):60-6. PubMed ID: 11840264
    [Abstract] [Full Text] [Related]

  • 26. 211At radioimmunotherapy of subcutaneous human ovarian cancer xenografts: evaluation of relative biologic effectiveness of an alpha-emitter in vivo.
    Bäck T, Andersson H, Divgi CR, Hultborn R, Jensen H, Lindegren S, Palm S, Jacobsson L.
    J Nucl Med; 2005 Dec 15; 46(12):2061-7. PubMed ID: 16330571
    [Abstract] [Full Text] [Related]

  • 27. Evaluation of Efficacy of Radioimmunotherapy with 90Y-Labeled Fully Human Anti-Transferrin Receptor Monoclonal Antibody in Pancreatic Cancer Mouse Models.
    Sugyo A, Tsuji AB, Sudo H, Okada M, Koizumi M, Satoh H, Kurosawa G, Kurosawa Y, Saga T.
    PLoS One; 2015 Dec 15; 10(4):e0123761. PubMed ID: 25893775
    [Abstract] [Full Text] [Related]

  • 28. Intralesional radioimmunotherapy with Yttrium-90-labeled human monoclonal IgM in nude mice bearing human tumor xenografts.
    Borchardt PE, Vriesendorp HM, Freedman RS, Quadri SM.
    Cancer Biother Radiopharm; 2004 Feb 15; 19(1):43-51. PubMed ID: 15068610
    [Abstract] [Full Text] [Related]

  • 29. The irradiation tolerance dose of the proximal vagina.
    Au SP, Grigsby PW.
    Radiother Oncol; 2003 Apr 15; 67(1):77-85. PubMed ID: 12758243
    [Abstract] [Full Text] [Related]

  • 30. Timing effects of combined radioimmunotherapy and radiotherapy on a human solid tumor in nude mice.
    Sun LQ, Vogel CA, Mirimanoff RO, Coucke P, Slosman DO, Mach JP, Buchegger F.
    Cancer Res; 1997 Apr 01; 57(7):1312-9. PubMed ID: 9102219
    [Abstract] [Full Text] [Related]

  • 31. A comparison of 131I-labeled monoclonal antibody 17-1A treatment to external beam irradiation on the growth of LS174T human colon carcinoma xenografts.
    Buchsbaum DJ, ten Haken RK, Heidorn DB, Lawrence TS, Glatfelter AA, Terry VH, Guilbault DM, Steplewski Z, Lichter AS.
    Int J Radiat Oncol Biol Phys; 1990 May 01; 18(5):1033-41. PubMed ID: 2347713
    [Abstract] [Full Text] [Related]

  • 32. 131I radioimmunotherapy and fractionated external beam radiotherapy: comparative effectiveness in a human tumor xenograft.
    Barendswaard EC, O'Donoghue JA, Larson SM, Tschmelitsch J, Welt S, Finn RD, Humm JL.
    J Nucl Med; 1999 Oct 01; 40(10):1764-8. PubMed ID: 10520720
    [Abstract] [Full Text] [Related]

  • 33. Improved treatment of medullary thyroid cancer in a nude mouse model by combined radioimmunochemotherapy: doxorubicin potentiates the therapeutic efficacy of radiolabeled antibodies in a radioresistant tumor type.
    Behr TM, Wulst E, Radetzky S, Blumenthal RD, Dunn RM, Gratz S, Rave-Fränk M, Schmidberger H, Raue F, Becker W.
    Cancer Res; 1997 Dec 01; 57(23):5309-19. PubMed ID: 9393755
    [Abstract] [Full Text] [Related]

  • 34. Patterns of brachytherapy practice for patients with carcinoma of the cervix (1996-1999): a patterns of care study.
    Erickson B, Eifel P, Moughan J, Rownd J, Iarocci T, Owen J.
    Int J Radiat Oncol Biol Phys; 2005 Nov 15; 63(4):1083-92. PubMed ID: 16099599
    [Abstract] [Full Text] [Related]

  • 35. Application of the cross-organ beta dose method for tissue dosimetry in tumor-bearing mice treated with a 90Y-labeled immunoconjugate.
    Beatty BG, Kuhn JA, Hui TE, Fisher DR, Williams LE, Beatty JD.
    Cancer; 1994 Feb 01; 73(3 Suppl):958-65. PubMed ID: 8306285
    [Abstract] [Full Text] [Related]

  • 36. Combined radioimmunotherapy and radiotherapy of human colon carcinoma grafted in nude mice.
    Buchegger F, Rojas A, Delaloye AB, Vogel CA, Mirimanoff RO, Coucke P, Sun LQ, Raimondi S, Denekamp J, Pèlgrin A.
    Cancer Res; 1995 Jan 01; 55(1):83-9. PubMed ID: 7805046
    [Abstract] [Full Text] [Related]

  • 37. Dosimetric evaluation and radioimmunotherapy of anti-tumour multivalent Fab' fragments.
    Casey JL, Pedley RB, King DJ, Green AJ, Yarranton GT, Begent RH.
    Br J Cancer; 1999 Nov 01; 81(6):972-80. PubMed ID: 10576653
    [Abstract] [Full Text] [Related]

  • 38. A quantitative study of radionuclide characteristics for radioimmunotherapy from 3D reconstructions using serial autoradiography.
    Muthuswamy MS, Roberson PL, Ten Haken RK, Buchsbaum DJ.
    Int J Radiat Oncol Biol Phys; 1996 Apr 01; 35(1):165-72. PubMed ID: 8641915
    [Abstract] [Full Text] [Related]

  • 39. Radioimmunotherapy of nude mice bearing a human interleukin 2 receptor alpha-expressing lymphoma utilizing the alpha-emitting radionuclide-conjugated monoclonal antibody 212Bi-anti-Tac.
    Hartmann F, Horak EM, Garmestani K, Wu C, Brechbiel MW, Kozak RW, Tso J, Kosteiny SA, Gansow OA, Nelson DL.
    Cancer Res; 1994 Aug 15; 54(16):4362-70. PubMed ID: 8044783
    [Abstract] [Full Text] [Related]

  • 40. Combined modality radioimmunotherapy for human prostate cancer xenografts with taxanes and 90yttrium-DOTA-peptide-ChL6.
    O'Donnell RT, DeNardo SJ, Miers LA, Lamborn KR, Kukis DL, DeNardo GL, Meyers FJ.
    Prostate; 2002 Jan 01; 50(1):27-37. PubMed ID: 11757033
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 73.